Literature DB >> 9722540

Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis.

R A Anders1, J J Doré, S L Arline, N Garamszegi, E B Leof.   

Abstract

Transforming growth factor beta (TGFbeta) superfamily polypeptides regulate cell growth and differentiation by binding to single pass serine/threonine kinases referred to as TGFbeta type I and type II receptors. Signal propagation is dependent upon heteromeric (type I-type II) complex formation and transphosphorylation of the type I receptor by the type II receptor. While many of the phosphorylation events necessary for receptor signaling have recently been characterized, the role of TGFbeta receptor kinase activity in modulating receptor endocytosis has not been addressed. To that end, we have used chimeric receptors consisting of the extracellular domain of the granulocyte/macrophage colony-stimulating factor alpha and beta receptors spliced to the TGFbeta type I and type II transmembrane and cytoplasmic domains to address the specific role of type I and/or type II receptor kinase activity in TGFbeta receptor internalization, down-regulation, and signaling. To inactivate chimeric receptor kinase activity, point mutations in the ATP binding site were made at amino acids 232 and 277 in the type I and type II receptor, respectively. Either of these mutations abolished plasminogen activator inhibitor 1 protein expression stimulated by granulocyte/macrophage colony-stimulating factor activation of chimeric heteromeric type I-type II TGFbeta receptors. They did not, however, modulate TGFbeta signaling stimulated through the endogenous TGFbeta receptor. Although TGFbeta receptor signaling was dependent upon the kinase activity of both chimeric receptors, the initial endocytic response was distinctly regulated by type I and/or type II receptor kinase activity. For instance, while heteromeric receptor complexes containing a kinase-inactive type I receptor were endocytosed similarly to wild type complexes, the kinase activity of the type II TGFbeta receptor was necessary for optimal internalization and receptor down-regulation. Furthermore, these responses were shown to occur independently of type II receptor autophosphorylation but require a type II receptor capable of transphosphorylation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722540     DOI: 10.1074/jbc.273.36.23118

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Mechanisms of transforming growth factor-beta receptor endocytosis and intracellular sorting differ between fibroblasts and epithelial cells.

Authors:  J J Doré; D Yao; M Edens; N Garamszegi; E L Sholl; E B Leof
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

2.  Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.

Authors:  Sumedha G Penheiter; Hugh Mitchell; Nandor Garamszegi; Maryanne Edens; Jules J E Doré; Edward B Leof
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

3.  Disruption of the murine Ap2β1 gene causes nonsyndromic cleft palate.

Authors:  Wei Li; Rosa Puertollano; Juan S Bonifacino; Paul A Overbeek; Eric T Everett
Journal:  Cleft Palate Craniofac J       Date:  2010-03-02

4.  Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masatoshi Jinnin; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 5.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

6.  IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.

Authors:  Chunsheng Liu; Daniel D Billadeau; Haitham Abdelhakim; Edward Leof; Kozo Kaibuchi; Carmelo Bernabeu; George S Bloom; Liu Yang; Lisa Boardman; Vijay H Shah; Ningling Kang
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

7.  Differential trafficking of transforming growth factor-beta receptors and ligand in polarized epithelial cells.

Authors:  S J Murphy; J J E Doré; M Edens; R J Coffey; J A Barnard; H Mitchell; M Wilkes; E B Leof
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

8.  Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2.

Authors:  Sumedha G Penheiter; Raman Deep Singh; Claire E Repellin; Mark C Wilkes; Maryanne Edens; Philip H Howe; Richard E Pagano; Edward B Leof
Journal:  Mol Biol Cell       Date:  2010-09-29       Impact factor: 4.138

9.  Development of a three dimensional multiscale computational model of the human epidermis.

Authors:  Salem Adra; Tao Sun; Sheila MacNeil; Mike Holcombe; Rod Smallwood
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

10.  Exploring hypotheses of the actions of TGF-beta1 in epidermal wound healing using a 3D computational multiscale model of the human epidermis.

Authors:  Tao Sun; Salem Adra; Rod Smallwood; Mike Holcombe; Sheila MacNeil
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.